Cubist Pharmaceuticals to Acquire Optimer Pharmaceuticals For $10.75 In Cash
July 30, 2013 at 16:46 PM EDT
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST ) and Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR ) today announced that they have signed a merger agreement under which Cubist will acquire all of the outstanding shares of Optimer common stock for $10.75 per share in cash, or approximately $535 million on a
